Mr. O’Connor is the Chief Executive Officer of OncoSec Medical, Inc., a biopharmaceutical company developing intratumoral cancer immunotherapies.
Dr. Twitty brings over 20 years of experience in tumor immunology and cancer immunotherapy, including the discovery and development of OncoSec’s leading clinical immune monitoring and biomarker program.
Ms. Bonstein brings more than 15 years of operational and financial leadership in the life sciences industry with Advaxis, Inc., Eli Lilly & Company, ImClone Systems, and Johnson & Johnson.
Ms. Malloy Foerter brings nearly thirty years of experience in clinical research with Syneos Health, inVentiv Health (previously PharmaNet), and Covance.
Mr. Loiacono brings more than 17 years of success across the life sciences and medical device industries, having held commercial, legal and business roles.
With more than 35 years of experience in the pharmaceutical industry, Dr. Ashworth is well-versed in drug development and global regulatory strategies and has made significant contributions to the FDA approval of 12 new drugs.
Mr. Rodriguez is a leader in product development with over 30 years of experience heading teams in the design, development and manufacture of products for the biomedical industry.
CEO & DIRECTOR
CO-FOUNDER / CHAIRMAN
CO-FOUNDER / DIRECTOR